Stocks-ROG.ZU-Roche Holding Ltd

ROG.ZU Roche Holding Ltd

263.70 -9.98 (-3.65%)
Trade
Trade

Roche Holding Ltd price

-8.11% Past Week
Created with Highcharts 4.2.7 /Highstock 4.2.7
Market Cap
218.48B
Day’s Range
262.30
-
275.68
52W Range
211.98
-
287.66
Volume (3M)
1.05M
Price-Earnings Ratio
20.58
Revenue
58.79B
Top Discussions
jwesth
United Kingdom
𝙄𝙨 𝙂𝙪𝙗𝙧𝙖 𝙩𝙝𝙚 𝙣𝙚𝙭𝙩 𝙬𝙚𝙞𝙜𝙝𝙩 𝙡𝙤𝙨𝙨 𝙬𝙞𝙣𝙣𝙚𝙧? 📈 Danish biotech company $GUBRA.CO (Gubra A/S) has skyrocketed in 2024 and is suddenly on the radar of many retail investors. Since its listing on Nasdaq Copenhagen at a price of DKK 110 in March 2023, the share price has risen by... Show More
Like CommentShare
null
.
AriesFund
📈Monthly Performance Report: August 2024 Dear Investors, Here is my first monthly update of AriesFund portfolio performance and key highlights: 📊 Performance Stats: - Return since inception (19-Jul-2024): ⬆️8.3% - $SPX500 benchmark (19-Jul-2024 to date): ⬆️1.5% - Outperformed the market by ⬆️6.8%... Show More
Like CommentShare
null
.
mpitrade
Roche Holding AG $ROG.ZU (Roche Holding Ltd) is a strong player in the pharmaceutical and diagnostics sectors, with a robust pipeline in oncology and personalized medicine. The company benefits from steady revenue growth, high margins, and strong cash flow, supporting consistent dividend payouts. Its... Show More
getloaded
Dear Investors and Copiers, 2024 Q2 for $LLY (Eli Lilly & Co) showed continuation of strong sales numbers. - Revenue up 36%, driven mainly by Mounjaro, Zepbound and Verzenio. - EPS up 86% (non-GAAP) demonstrating economies of scale along with strong control of costs as business keeps on expanding. -... Show More
jwesth
United Kingdom
Edited
𝙎𝙤𝙡𝙞𝙙 𝙧𝙚𝙨𝙪𝙡𝙩𝙨 𝙛𝙧𝙤𝙢 𝘽𝙖𝙫𝙖𝙧𝙞𝙖𝙣 𝙉𝙤𝙧𝙙𝙞𝙘, 𝙗𝙪𝙩 𝙘𝙖𝙣 𝙩𝙝𝙚 ‘𝙢𝙥𝙤𝙭 𝙫𝙖𝙘𝙘𝙞𝙣𝙚 𝙥𝙧𝙚𝙢𝙞𝙪𝙢’ 𝙝𝙤𝙡𝙙? ⚕️ Danish vaccine manufacturer $BAVA.CO (Bavarian Nordic A/S) delivered solid first half-year results this morning with higher-than-expected revenue and operating... Show More
Like CommentShare
null
.
ThomasSalwasser
Hallo liebe Community, nach einer kurzen Talfahrt am breiten Markt scheinen sich die Aktien nun wieder nach oben zu entwickeln. Der $GER40 durchschritt wieder die 18000er Marke und passt sich der Entwicklung auf dem US Markt an. Positiv für alle, die in den USA Urlaub machen wollen: der $EURUSD sorgt... Show More Translate
jwesth
United Kingdom
Edited
𝙄𝙨 𝙕𝙚𝙖𝙡𝙖𝙣𝙙 𝙋𝙝𝙖𝙧𝙢𝙖 𝙩𝙝𝙚 𝙣𝙚𝙭𝙩 𝙉𝙤𝙫𝙤 𝙉𝙤𝙧𝙙𝙞𝙨𝙠? 🔬 Danish biotech company $ZEAL.CO (Zealand Pharma A/S) has recently presented its results for the first quarter of 2024. As an 'R&D shop' focused on developing new drugs, Zealand Pharma differs from most other companies... Show More
Like CommentShare
null
.
NicoScarabello
𝙉𝙤𝙫𝙤 𝙉𝙤𝙧𝙙𝙞𝙨𝙠 𝟮𝟬𝟮𝟰 𝙌𝟮 𝙚𝙖𝙧𝙣𝙞𝙣𝙜 𝙧𝙚𝙥𝙤𝙧𝙩 $NOVO-B.CO (Novo Nordisk B A/S) Released their Q2 earnings report this week. ᴀʙᴏᴜᴛ ᴛʜᴇ ᴄᴏᴍᴘᴀɴʏ Novo Nordisk is a global healthcare company headquartered in Denmark, specializing in the development, manufacture, and marketing of pharmaceutical... Show More
Like CommentShare
3 replies
null
.
Askorpus
Hello, Looking at the past two weeks gives us several important incentives: - Volatility is natural part of the stock market, therefore is not something good or bad, just an opportunity; - The market tends to overreact - largely as a result of most people misjudging or misunderstanding certain factors,... Show More
Like CommentShare
null
.
Askorpus
Want a stable, long-term portfolio? - 9.56% Return YTD; - 3.1% dividend yield; - diversification among various sectors and industries; - stable, market-leading companies with huge growth potential. Copy my portfolio and take advantage of the above. Feel free to ask whatever questions come to mind. $TXN... Show More
Like CommentShare
null
.

About Roche Holding Ltd

Roche Holding AG (ROG.ZU) is a Swiss healthcare company, founded in 1896. The company is based in Basel, providing services in both pharmaceuticals and diagnostics. ROG enjoys a net income and total equity that number in the billions of Swiss Francs, making it one of the largest healthcare companies in the world. It has a history of aggressive expansion, including the purchase of numerous companies throughout its long and successful history. ROG has many shareholders, with the founding families still owning a majority stake. ROG.ZU stock value has remained strong overall for the past several years. The company is listed on the Six Swiss Stock Exchange. One of the primary reasons for Roche Holdings AG’s success on the stock market is the purchase of many leading pharmaceutical firms, with the purchase of Genentech for $46.8 billion in 2009 being the most noteworthy. It should be noted that the company has previously issued bearer shares. However, Swiss regulatory changes will soon render this type of stock illegal, as the country aligns itself with other OECD nations. Investors can track the ROG.ZU price on the eToro platform in real-time. Add this stock to your trading portfolio now.
Thomas Schinecker, PhD
CEO
103.6K
Employees
1896
Founded
CH
HQ
Show More

ESG: A New Source of Insight

Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
66
Very High
Industry 
Avg. 46 
70
Environment
67
Social
61
Governance

Business Involvement Flags

People Also Bought